Biomarkers for acute diagnosis and management of stroke in neurointensive care units
暂无分享,去创建一个
A. Valadka | R. Hayes | Olena Y. Glushakova | Alex B Valadka | Ronald L Hayes | Emmy R. Miller | A. Glushakov | Olena Y Glushakova | Alexander V Glushakov | Emmy R Miller | E. Miller
[1] J. Pujol,et al. Experimental Brain Ischemia: Neuron‐Specific Enolase Level in Cerebrospinal Fluid as an Index of Neuronal Damage , 1984, Journal of neurochemistry.
[2] Hester F. Lingsma,et al. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. , 2013, Journal of neurotrauma.
[3] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[4] Y. Olsson,et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. , 1989, Journal of neurosurgery.
[5] M. Elkind,et al. Potential Role of Blood Biomarkers in the Management of Nontraumatic Intracerebral Hemorrhage , 2014, Cerebrovascular Diseases.
[6] M. van Gils,et al. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury. , 2016, World neurosurgery.
[7] L. Eng. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes , 1985, Journal of Neuroimmunology.
[8] E. Arias,et al. Mortality in the United States, 2013. , 2014, NCHS data brief.
[9] Hester F. Lingsma,et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. , 2014, Journal of neurotrauma.
[10] Yueh-Yun Chi,et al. Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage , 2010, Journal of neuroscience research.
[11] Neuron Specific Enolase and C-reactive Protein Levels in Stroke and Its Subtypes: Correlation with Degree of Disability , 2014, Neurochemical Research.
[12] L. Stead,et al. Neuron-Specific Enolase as a Marker for Acute Ischemic Stroke: A Systematic Review , 2005, Cerebrovascular Diseases.
[13] O. Tasaki,et al. CHANGES IN CSF S100B AND CYTOKINE CONCENTRATIONS IN EARLY-PHASE SEVERE TRAUMATIC BRAIN INJURY , 2004, Shock.
[14] Chang-Hyun Lee,et al. A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury , 2015, Journal of Korean Neurosurgical Society.
[15] J Bamford,et al. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. , 1987, Stroke.
[16] I. Rizvi,et al. Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke , 2013, Annals of Indian Academy of Neurology.
[17] W. Pfeilschifter,et al. Saures Gliafaserprotein beim Patienten mit akuten Schlaganfallsymptomen , 2014, Der Nervenarzt.
[18] J. Montaner,et al. Plasmatic retinol‐binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage , 2016, Journal of neurochemistry.
[19] Wuping Xu,et al. The use of serum glial fibrillary acidic protein test as a promising tool for intracerebral hemorrhage diagnosis in Chinese patients and prediction of the short-term functional outcomes , 2015, Neurological Sciences.
[20] H. Reichmann,et al. Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke , 2009, Stroke.
[21] H. Ulmer,et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury , 2003, Neurology.
[22] H. Özgüç,et al. Tau protein as a serum marker of brain damage in mild traumatic brain injury: Preliminary results , 2006, Advances in therapy.
[23] B. Trapp,et al. NG2+ glial cells: a novel glial cell population in the adult brain. , 1999, Journal of neuropathology and experimental neurology.
[24] R. Neumar,et al. Comparison of Calpain and Caspase Activities in the Adult Rat Brain after Transient Forebrain Ischemia , 2002, Neurobiology of Disease.
[25] M. Sitzer,et al. Characterisation of the Diagnostic Window of Serum Glial Fibrillary Acidic Protein for the Differentiation of Intracerebral Haemorrhage and Ischaemic Stroke , 2008, Cerebrovascular Diseases.
[26] E. Thelin,et al. S100B is an important outcome predictor in traumatic brain injury. , 2013, Journal of neurotrauma.
[27] T. Neumann-Haefelin,et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[28] K. Blennow,et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke , 2001, Neuroscience Letters.
[29] F. Tortella,et al. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury , 2016, Journal of neurotrauma.
[30] O. Benavente,et al. Stroke: part II. Management of acute ischemic stroke. , 1999, American family physician.
[31] C. Robertson,et al. GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. , 2014, Journal of neurotrauma.
[32] M. Verbeek,et al. An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid. , 2005, Journal of immunological methods.
[33] Yan Chen,et al. The accuracy of glial fibrillary acidic protein in acute stroke differential diagnosis: A meta-analysis , 2013, Scandinavian journal of clinical and laboratory investigation.
[34] K. Blennow,et al. Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. , 2000, Journal of Alzheimer's disease : JAD.
[35] J. Levine,et al. Light and electron microscopic localization of a cell surface antigen (NG2) in the rat cerebellum: association with smooth protoplasmic astrocytes , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] D. Duan,et al. Serum UCH-L1 as a Novel Biomarker to Predict Neuronal Apoptosis Following Deep Hypothermic Circulatory Arrest , 2015, International journal of medical sciences.
[37] E. Waxman,et al. Interactions of Postsynaptic Density-95 and the NMDA Receptor 2 Subunit Control Calpain-Mediated Cleavage of the NMDA Receptor , 2004, The Journal of Neuroscience.
[38] L. Pradel,et al. Interaction domains of neurofilament light chain and brain spectrin. , 1991, The Biochemical journal.
[39] N. Hadker,et al. A Literature Review of the Feasibility of Glial Fibrillary Acidic Protein as a Biomarker for Stroke and Traumatic Brain Injury , 2012, Molecular Diagnosis & Therapy.
[40] S. Suckow,et al. Expression of the N-methyl-d-aspartate receptor NR1 splice variants and NR2 subunit subtypes in the rat colon , 2007, Neuroscience.
[41] B. Kim,et al. The second elevation of neuron-specific enolase peak after ischemic stroke is associated with hemorrhagic transformation. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[42] R. Hayes,et al. Different expression of ubiquitin C-terminal hydrolase-L1 and αII-spectrin in ischemic and hemorrhagic stroke: Potential biomarkers in diagnosis , 2013, Brain Research.
[43] K. Haglid,et al. Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction , 1991, Stroke.
[44] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[45] J. Baudier,et al. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein. , 1986, The Journal of biological chemistry.
[46] Jeremiah R. Brown,et al. Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial , 2014, PloS one.
[47] A. Kastrup,et al. Circulating Damage Marker Profiles Support a Neuroprotective Effect of Erythropoietin in Ischemic Stroke Patients , 2011, Molecular medicine.
[48] J. Benson,et al. Expression of mRNA for the N-methyl-d-aspartate (NMDAR1) receptor by the enteric neurons of the rat , 1994, Neuroscience Letters.
[49] P. Hand,et al. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. , 2006, QJM : monthly journal of the Association of Physicians.
[50] K. Blennow,et al. CSF –Neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage , 2006, Neuroscience Letters.
[51] J. Montaner. Stroke biomarkers: can they help us to guide stroke thrombolysis? , 2006, Timely topics in medicine. Cardiovascular diseases.
[52] D. Souza,et al. Neuron-Specific Enolase, S100B, and Glial Fibrillary Acidic Protein Levels as Outcome Predictors in Patients With Severe Traumatic Brain Injury , 2011, Neurosurgery.
[53] Craig S. Anderson,et al. Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies , 2005, Stroke.
[54] D. Creery,et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[55] A. K. Erenler,et al. Usefulness of S100B protein in neurological disorders. , 2011, JPMA. The Journal of the Pakistan Medical Association.
[56] A. Shrivastava,et al. Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[57] E. Gundelfinger,et al. Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function , 1999, Cell and Tissue Research.
[58] E. Lesaffre,et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. , 1999, Stroke.
[59] C. Robertson,et al. Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury , 2007 .
[60] Hester F. Lingsma,et al. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. , 2015, Journal of neurotrauma.
[61] V. Feigin,et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.
[62] J. Trojanowski,et al. Total and phosphorylated tau protein as biological markers of Alzheimer’s disease , 2010, Experimental Gerontology.
[63] The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. , 1988, Journal of clinical epidemiology.
[64] Yuyuan Li,et al. Changes of ubiquitin C-terminal hydrolase-L1 levels in serum and urine of patients with white matter lesions , 2015, Journal of the Neurological Sciences.
[65] A. Gabrielli,et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. , 2011, Journal of neurotrauma.
[66] A. Skoromets,et al. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. , 2003, Clinical chemistry.
[67] H. Weng,et al. Tau proteins in serum predict outcome after severe traumatic brain injury. , 2010, The Journal of surgical research.
[68] S. Selvin,et al. The burden, trends, and demographics of mortality from subarachnoid hemorrhage , 1998, Neurology.
[69] Jason K. W. Lee,et al. S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise , 2014, Sports Medicine.
[70] S Claiborne Johnston,et al. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling , 2009, The Lancet Neurology.
[71] A. Gabrielli,et al. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. , 2010, Journal of neurotrauma.
[72] Y. Olsson,et al. Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid. , 1988, Stroke.
[73] A. Ferbert,et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. , 2012, Clinical chemistry.
[74] F. Tortella,et al. Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[75] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[76] Korf,et al. Neurone‐specific enolase and N‐acetyl‐aspartate as potential peripheral markers of ischaemic stroke , 1999, European journal of clinical investigation.
[77] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .
[78] D. Stejskal,et al. Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke: a pilot study. , 2011, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[79] A. Yıldırım,et al. Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases , 2015, Pakistan journal of medical sciences.
[80] R. Bateman,et al. Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[81] Jing Zhao,et al. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury , 2011, Neurotherapeutics.
[82] M. Díaz-Guerra,et al. Transcription of the NR1 Subunit of the N-Methyl-d-aspartate Receptor Is Down-regulated by Excitotoxic Stimulation and Cerebral Ischemia * , 2005, Journal of Biological Chemistry.
[83] N. Ilhan,et al. Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage , 2015, Medicine.
[84] Catherine B. Chan,et al. The Neuronal Ca2+ Sensor Protein Visinin-like Protein-1 Is Expressed in Pancreatic Islets and Regulates Insulin Secretion* , 2006, Journal of Biological Chemistry.
[85] Manfred Herrmann,et al. Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.
[86] D. Muresanu,et al. GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases , 2015, Journal of cellular and molecular medicine.
[87] Z. Stelmasiak,et al. Does Serum Tau Protein Predict the Outcome of Patients with Ischemic Stroke? , 2011, Journal of Molecular Neuroscience.
[88] C. D. Sharp,et al. Human Neuroepithelial Cells Express NMDA Receptors , 2003, BMC Neuroscience.
[89] A. Gabrielli,et al. Use of biomarkers for diagnosis and management of traumatic brain injury patients. , 2008, Expert opinion on medical diagnostics.
[90] J. Serena,et al. Applicability of Biomarkers in Ischemic Stroke , 2007, Cerebrovascular Diseases.
[91] R. Sprengelmeyer,et al. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. , 1997, Stroke.
[92] F. Tortella,et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. , 2012, Annals of emergency medicine.
[93] M. Varma,et al. Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke , 2011, Indian Journal of Clinical Biochemistry.
[94] M. Skalej,et al. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke , 2006, Clinical Neurology and Neurosurgery.
[95] J. Weissman,et al. Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke , 2012, PloS one.
[96] R. Hayes,et al. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats. , 2015, Journal of neurotrauma.
[97] T. Beems,et al. GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.
[98] M. Schwaninger,et al. Serum Protein S100β is a Diagnostic Biomarker for Distinguishing Posterior Circulation Stroke from Vertigo of Nonvascular Causes , 2014, European Neurology.
[99] O. Granstrem,et al. Expression of NMDA Neuroreceptors in Experimental Ischemia , 2003, Biochemistry (Moscow).
[100] K. Blennow,et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury , 2004, Neurology.
[101] T. Walilko,et al. Ubiquitin Carboxy-Terminal Hydrolase-L1 as a Serum Neurotrauma Biomarker for Exposure to Occupational Low-Level Blast , 2015, Front. Neurol..
[102] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[103] Bin Zhang,et al. Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis , 2015, Journal of the Neurological Sciences.
[104] M. Wunderlich,et al. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke , 2004, Journal of the Neurological Sciences.
[105] B. Winblad,et al. Brain and Plasma Proteins in Spinal Fluid as Markers for Brain Damage and Severity of Stroke , 1984, Stroke.
[106] M. Hennerici,et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke , 1997, Journal of the Neurological Sciences.
[107] N. Maurits,et al. Comparison of serum S-100 protein levels following stroke and traumatic brain injury , 2000, Journal of the Neurological Sciences.
[108] A. Fagan,et al. Visinin‐like protein‐1: Diagnostic and prognostic biomarker in Alzheimer disease , 2011, Annals of neurology.
[109] C. Molina,et al. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. , 2012, Journal of proteomics.
[110] K. Blennow,et al. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. , 1999, Neurology.
[111] S. Beers,et al. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. , 2012, Journal of neurotrauma.
[112] V. Seifert,et al. Serum S-100B protein as a molecular marker in severe traumatic brain injury. , 2003, Restorative neurology and neuroscience.
[113] A. Fabio,et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. , 2013, Journal of neurotrauma.
[114] T. Kaneko,et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. , 2010, The Journal of trauma.
[115] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[116] A. González-Quevedo,et al. Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. , 2012, Clinical biochemistry.
[117] J. Weissman,et al. NR2 antibodies: Risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events , 2011, Journal of the Neurological Sciences.
[118] B. Bakota,et al. Secondary stroke in patients with polytrauma and traumatic brain injury treated in an Intensive Care Unit, Karlovac General Hospital, Croatia. , 2015, Injury.
[119] H. Kumar,et al. To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication , 2015, Journal of neurosciences in rural practice.
[120] K. Blennow,et al. Journal of Central Nervous System Disease , 2022 .
[121] K. Becker,et al. Promiscuity of autoimmune responses to MBP after stroke , 2015, Journal of Neuroimmunology.
[122] C. Wikkelsø,et al. Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF , 1996, Journal of neurochemistry.
[123] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.
[124] F. Tortella,et al. Ubiquitin C‐terminal hydrolase‐L1 as a biomarker for ischemic and traumatic brain injury in rats , 2010, The European journal of neuroscience.
[125] R. Donato,et al. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.
[126] J. Leitgeb,et al. Analysis of S100 calcium binding protein B serum levels in different types of traumatic intracranial lesions. , 2015, Journal of neurotrauma.
[127] R. Hayes,et al. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways , 2009, Apoptosis.
[128] V. Feigin,et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.
[129] E. Gouaux,et al. Subunit arrangement and function in NMDA receptors , 2005, Nature.
[130] J. Baudier,et al. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation , 2004, Molecular and Cellular Neuroscience.
[131] R. Jaeschke,et al. Biochemical markers in acute ischemic stroke. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[132] K. Furie,et al. Molecular biomarkers in stroke diagnosis and prognosis. , 2009, Biomarkers in medicine.
[133] D. Thomas,et al. SERUM-MYELIN-BASIC-PROTEIN ASSAY IN DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH HEAD INJURY , 1978, The Lancet.
[134] S. Wisniewski,et al. Serum S100B concentrations are increased after closed head injury in children: a preliminary study. , 2002, Journal of neurotrauma.
[135] M. Polymeropoulos,et al. Sequence characterization and genetic mapping of the human VSNL1 gene, a homologue of the rat visinin-like peptide RNVP1. , 1995, Genomics.
[136] S. Beers,et al. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. , 2007, Journal of neurotrauma.
[137] A. Gabrielli,et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. , 2012, Journal of neurotrauma.
[138] S. Mckinstry,et al. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction , 1991, European journal of clinical investigation.
[139] R. Leak,et al. Demyelination as a rational therapeutic target for ischemic or traumatic brain injury , 2015, Experimental Neurology.
[140] C. Wilder-Smith,et al. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation. , 2014, Neuro endocrinology letters.
[141] F. de Pasquale,et al. Cerebrospinal fluid and serum neuron‐specific enolase concentrations in a normal population * , 2005, European journal of neurology.
[142] R. Hayes,et al. Glial fibrillary acidic protein: a promising biomarker in pediatric brain injury. , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[143] J. Garthwaite,et al. Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke , 1997, Annals of clinical biochemistry.
[144] R. Herndon,et al. Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination. , 1976, Transactions of the American Neurological Association.
[145] Matthew A. Eisenberg,et al. Serum biomarkers predict acute symptom burden in children after concussion: a preliminary study. , 2014, Journal of neurotrauma.
[146] M. Díaz-Guerra,et al. Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95 , 2008, Molecular Psychiatry.
[147] P. Deb,et al. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. , 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.
[148] S. Martin-Schild,et al. Early Neurological Deterioration (END) after Stroke: The END Depends on the Definition , 2011, International journal of stroke : official journal of the International Stroke Society.
[149] T. Kuno,et al. cDNA cloning of a neural visinin-like Ca(2+)-binding protein. , 1992, Biochemical and biophysical research communications.
[150] L Bozzao,et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.
[151] R. Mckernan,et al. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model , 1992, Brain Research.
[152] K. Cain,et al. Myelin basic protein autoantibodies, white matter disease and stroke outcome , 2012, Journal of Neuroimmunology.
[153] S. Rosenbaum,et al. Prediction and prognostication of neurological deterioration in patients with acute ICH: a hospital-based cohort study , 2015, BMJ Open.
[154] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[155] B. Norrving,et al. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation , 2009, Journal of Neurology.
[156] J. Broderick,et al. Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study , 2006, Stroke.
[157] D. Menon,et al. GFAP and UCH-L 1 as outcome predictors in traumatic brain injury , 2015 .
[158] S. Stein,et al. Evidence that a Panel of Neurodegeneration Biomarkers Predicts Vasospasm, Infarction, and Outcome in Aneurysmal Subarachnoid Hemorrhage , 2011, PloS one.
[159] H. Hårdemark,et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.
[160] K. Blennow,et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury , 2008, Acta Neurochirurgica.
[161] M. Kloss,et al. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection , 2015, Cerebrovascular Diseases.
[162] K. Blennow,et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury , 2006, Neurology.
[163] D. Lynch,et al. Proteolysis of theN-Methyl-d-Aspartate Receptor by Calpain in Situ , 2002, Journal of Pharmacology and Experimental Therapeutics.
[164] W. Pfeilschifter,et al. [Glial fibrillary acidic protein in patients with symptoms of acute stroke: diagnostic marker of cerebral hemorrhage]. , 2014, Der Nervenarzt.
[165] F. Barone,et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia , 1993, Brain Research.
[166] WolfHarald,et al. Analysis of S100 Calcium Binding Protein B Serum Levels in Different Types of Traumatic Intracranial Lesions , 2015 .
[167] S. Carmichael,et al. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. , 2015, Current opinion in neurology.
[168] Jesus Avila,et al. Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.
[169] M. Wiesmann,et al. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. , 1997, Stroke.
[170] C. Kavalci,et al. The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. , 2007, The American journal of emergency medicine.
[171] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[172] Gelin Xu,et al. Correlation between cerebral microbleeds and S100B/RAGE in acute lacunar stroke patients , 2014, Journal of the Neurological Sciences.
[173] D. Holtzman,et al. CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease , 2012, Neurology.
[174] D. Attwell,et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.
[175] A. Gabrielli,et al. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. , 2009, Journal of neurotrauma.
[176] R. Hayes,et al. Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. , 2007, Journal of neurosurgery.
[177] Á. Ruibal,et al. Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke , 1986, Acta neurologica Scandinavica.
[178] A. Gabrielli,et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury* , 2010, Critical care medicine.
[179] Jin-Moo Lee,et al. Identification of novel brain biomarkers. , 2006, Clinical chemistry.
[180] G. Thomalla,et al. Wake-Up Stroke: Clinical Characteristics, Imaging Findings, and Treatment Option – an Update , 2013, Front. Neurol..
[181] Yu-qing Yan,et al. The prognostic value of serum tau in patients with intracerebral hemorrhage. , 2012, Clinical biochemistry.
[182] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .